Page 3 - Rodney Varner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genprex (GNPX) Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators

Genprex (GNPX) Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMeharry medical collegeRodney varnerMitochondrial metabolism at meharry medical collegeGenprex incResearch agreementsRogel cancer center judith tamUniversity of michigan rogel cancer centerDrug administrationLung cancer research initiativeSponsored research agreementsMaterial transfer agreementsChief executive officerNanoparticle delivery systemMichigan rogel cancerMichigan rogel cancer center judith tam

Genprex (GNPX) Provides Business Update and Outlook for 2024

Genprex (GNPX) Provides Business Update and Outlook for 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRussia generalRodney varnerAstrazeneca tagrissoSafety review committeeMerck coUniversity of pittsburghGenentech incInternational conference on molecularAmerican association for cancer researchGenprex incDrug administrationChief executive officerFast track designationImmunogene therapyOrphan drug designation

NetworkNewsWire: Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

NetworkNewsWire: Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesBaden wübergSophia randolphGenentech tecentriqRodney varnerExchange commissionGenentech incJazz pharmaceuticalsGenprex incDrug administrationEuropean commissionUs food drug administrationOncology holdings incNational library of medicineAchilles therapeutics

Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies.

United statesSuzanne thornton jonesRodney varnerCompany websitePrnewswire genprex incTeam lead at affinia therapeuticsHead of regulatory affairsRegulatory affairsTeam lead at tavanta therapeuticsUniversity of pennsylvania perelman school medicineDrug administrationGenprex incVirginia commonwealth universityExchange commissionGene therapy programNon small cell lung cancer

Genprex bags FDA orphan drug designation for lung cancer therapy

Genprex has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its lead candidate, Reqorsa immunogene therapy (quaratusugene ozeplasmid), for the treatment of small cell lung cancer (SCLC).

United statesRodney varnerGenentech tecentriqReqorsa immunogeneOrphan drug designationDrug designationBio developmentsFood and drug administrationLung cancer